ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $8,000 | +33.3% | 2,500 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $6,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,000 | -37.5% | 2,500 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $8,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $8,000 | +33.3% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $6,000 | +50.0% | 2,500 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $4,000 | +33.3% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $3,000 | +50.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $2,000 | -33.3% | 2,500 | 0.0% | 0.00% | -66.7% |
Q4 2015 | $3,000 | -72.7% | 2,500 | +150.0% | 0.00% | -40.0% |
Q3 2015 | $11,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |